PFE — Pfizer Inc. stock price and chart

PFE

Pfizer Inc.Stock · HealthcareS&P 500 0.2% · Russell 1000 0.2% · US Stock Market 0.2% · Russell 3000 0.2% · S&P 500 Equal Weight 0.2% · MSCI World 0.2% · MSCI ACWI 0.2% · Emerging Markets 0.001%

$27.72+0.25%

as of market close, Sep 11, 2026

☾ AH $27.69 -0.11%

PeersMRNALLYUNHJNJMRKABBV

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

25.030.035.040.045.050.055.00500.0M$27.72

2026-09-11

Price$27.72

MA20$26.28

MA50$25.75

Vol165.7M

What would $1,000 invested in PFE be worth today? →

PFE returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $27.72
Change YTD: +17.07%
Next earnings: Nov 3, 2026
Market cap: 158B2016-09 194.9B2026-09 157.9B-19.0% over the window
Enterprise value: 223B
Shares outstanding: 5.7B2016-07 6.1B2026-06 5.7B-6.0% over the window
52W low: $23.58
52W high: $29.21
From 52W high: -5.10%
From 52W low: +17.56%
52W range: 74%
Beta: 0.33

Volume

Rel volume: 0.70×
30D volume: 36.7M
30D $ vol: 999.6M

Fundamentals

Sales (ttm): 63.7B2016-12 52.8B2026-06 63.7B+20.6% over the window
Sales/share: $11.182016-12 $8.882026-06 $11.18+25.9% over the window
EPS (ttm): $0.762016-07 $1.132026-06 $0.76-33.1% over the window
FCF (ttm): 11B2016-07 13.7B2026-06 11B-20.0% over the window
FCF/share: $1.932016-07 $2.262026-06 $1.93-14.9% over the window
Book value/share: $14.952016-07 $10.352026-06 $14.95+44.4% over the window
Net margin: 6.80%2016-12 13.7%2026-06 6.8%-50.2% over the window
ROE: 5.09%2016-07 11.2%2026-06 5.1%-54.7% over the window
ROA: 2.15%2016-07 4.1%2026-06 2.2%-47.8% over the window
Debt / equity: 0.71×2016-07 0.492026-06 0.71+46.3% over the window
Current ratio: 1.272016-07 1.372026-06 1.27-7.3% over the window

Growth (CAGR, ttm) · 10Y

Sales: -0.22%2025-06-29 → 2026-06-2863.8B → 63.7B (-0.2% total)-3.05%2023-07-02 → 2026-06-2869.9B → 63.7B (-8.9% total)+2.95%2021-07-04 → 2026-06-2855.1B → 63.7B (+15.6% total)+1.99%2016-12-31 → 2026-06-2852.8B → 63.7B (+20.6% total)
Net income: -59.84%2025-06-29 → 2026-06-2810.8B → 4.3B (-59.7% total)-41.46%2023-07-02 → 2026-06-2821.5B → 4.3B (-79.8% total)-19.48%2021-07-04 → 2026-06-2812.8B → 4.3B (-66.0% total)-4.75%2016-07-03 → 2026-06-287B → 4.3B (-38.5% total)
FCF: -11.72%2025-06-29 → 2026-06-2812.4B → 11B (-11.7% total)+0.99%2023-07-02 → 2026-06-2810.7B → 11B (+3.0% total)-12.31%2021-07-04 → 2026-06-2821.1B → 11B (-48.0% total)-2.21%2016-07-03 → 2026-06-2813.7B → 11B (-20.0% total)
Shares: +0.25%2025-06-29 → 2026-06-285.7B → 5.7B (+0.2% total)+0.32%2023-07-02 → 2026-06-285.6B → 5.7B (+1.0% total)+0.33%2021-07-04 → 2026-06-285.6B → 5.7B (+1.7% total)-0.62%2016-07-03 → 2026-06-286.1B → 5.7B (-6.0% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: -59.91%2025-06-29 → 2026-06-28$1.88 → $0.76 (-59.8% total)-41.43%2023-07-02 → 2026-06-28$3.75 → $0.76 (-79.8% total)-19.65%2021-07-04 → 2026-06-28$2.25 → $0.76 (-66.4% total)-3.95%2016-07-03 → 2026-06-28$1.13 → $0.76 (-33.1% total)
Sales/share: -0.46%2025-06-29 → 2026-06-28$11.23 → $11.18 (-0.5% total)-3.36%2023-07-02 → 2026-06-28$12.38 → $11.18 (-9.7% total)+2.61%2021-07-04 → 2026-06-28$9.83 → $11.18 (+13.7% total)+2.46%2016-12-31 → 2026-06-28$8.88 → $11.18 (+25.9% total)
FCF/share: -11.94%2025-06-29 → 2026-06-28$2.19 → $1.93 (-11.9% total)+0.67%2023-07-02 → 2026-06-28$1.89 → $1.93 (+2.0% total)-12.60%2021-07-04 → 2026-06-28$3.77 → $1.93 (-48.9% total)-1.60%2016-07-03 → 2026-06-28$2.26 → $1.93 (-14.9% total)
Book value/share: -4.20%2025-06-29 → 2026-06-28$15.60 → $14.95 (-4.2% total)-5.21%2023-07-02 → 2026-06-28$17.54 → $14.95 (-14.8% total)+3.66%2021-07-04 → 2026-06-28$12.49 → $14.95 (+19.6% total)+3.75%2016-07-03 → 2026-06-28$10.35 → $14.95 (+44.4% total)
Dividend/share: +0.59%2025-06-29 → 2026-06-28$1.71 → $1.72 (+0.6% total)+1.81%2023-07-02 → 2026-06-28$1.63 → $1.72 (+5.5% total)+2.11%2021-07-04 → 2026-06-28$1.55 → $1.72 (+11.0% total)+4.02%2016-07-03 → 2026-06-28$1.16 → $1.72 (+48.3% total)
Price: +11.51%2025-09-11 → 2026-09-11$24.86 → $27.72 (+11.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-6.52%2023-09-11 → 2026-09-11$33.94 → $27.72 (-18.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-9.47%2021-09-10 → 2026-09-11$45.59 → $27.72 (-39.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-1.53%2016-09-09 → 2026-09-11$32.35 → $27.72 (-14.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +19.34%2025-09-11 → 2026-09-11$23.23 → $27.72 (+19.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-0.32%2023-09-11 → 2026-09-11$27.99 → $27.72 (-0.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-4.55%2021-09-10 → 2026-09-11$34.99 → $27.72 (-20.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+3.04%2016-09-09 → 2026-09-11$20.54 → $27.72 (+35.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 36.6×2016-09 27.682026-09 36.45+31.7% over the window
Fwd P/E: 9.7×
P/S (ttm)Market cap ÷ TTM revenue.: 2.5×2016-09 3.872026-09 2.48-36.0% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 1.9×2016-09 3.112026-09 1.85-40.3% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 14.4×2016-09 14.202026-09 14.37+1.2% over the window
EV/EBITDA (fy): 16.6×
EV/Sales (ttm): 3.5×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 6.95%2016-07 7.0%2026-06 8.0%+13.2% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 6.20%
Dividend/share (fwd): $1.72
Buyback yield (realized, 1y)1 − shares_at(2026-06-28) ÷ shares_at(2025-06-29) = 1 − 5.70B ÷ 5.69B. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -0.25%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-0.25%) + dividends paid over that year ($9.8B) ÷ market_cap_at(2025-06-29) ($137.5B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 6.87%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($158B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2016-07 3.1%2026-06 0.0%-100.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $9.8B) ÷ today's market cap ($158B). Same caveat as the cash buyback yield.: 6.19%2016-07 6.7%2026-06 7.1%+5.8% over the window

Vs own 10Y history

P/E: 96th
P/S: 20th
P/B: 26th
P/FCF: 45th

Bar = where today’s multiple sits in PFE’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

+0.25%

-3.78%

+5.36%

+7.78%

YTD

+17.07%

+20.73%

-22.89%

Financial statements

Open full PFE financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%

Pfizer Inc. (PFE) trades at $27.72 with a live price and an interactive chart covering 54+ years of daily price history, plus key valuation metrics. ChartRow also publishes PFE’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full PFE financial statements →

PFE — Pfizer Inc. price, chart and key statistics